The storied success of copyright’s flagship drug has undeniably influenced the pharmaceutical landscape. However, putting money in companies heavily dependent on biosimilars and the diminishing patent exclusivity surrounding this iconic medication presents a notable degree of risk . While major pharma firms may still benefit from related therapie

A thorough sector review is vital for identifying the current trends at work. This study delves into key aspects influencing the contested space, from new technologies and shifting consumer preferences to regulatory challenges and monetary risks. We’ll evaluate the overall outlook, including likely growth areas, risks to existing players, and the